Brain Mechanisms of Reducing Polysubstance Use Following a Novel Body-mind Intervention

Clinical Trial ID: NCT04261504

Description

The proposed study will examine brain mechanisms of a brief mindfulness intervention - IBMT on ATC reduction.

The R61 phase of the proposed study will examine brain mechanisms of a brief mindfulness intervention - IBMT that targets at self-control networks in the brain, and test IBMT effects on ATC reduction.


Criteria

Inclusion Criteria: - (1) at least 18 years old; - (2) free of any psychiatric diagnoses or medication (besides a SUD to alcohol, tobacco, or cannabis); - (3) in the past month, at least 4 episode of heavy episodic drinking; at least 3 occasion of cannabis use; and daily cigarette use for at least the past month; - (4) normal or corrected-to-normal vision; - (5) written informed consent; - (6) no previous meditation or NF experiences. Exclusion Criteria: - (1) any psychiatric diagnoses other than an SUD; - (2) medical disorder(s) that may affect the central nervous system; medications that affect the central and autonomic nervous system; or a positive pregnancy test result (females); - (3) excluding cannabis, evidence of recent (past month) illicit drug use.

  • Start Date

    2019-04-29

  • Last Updated

    2020-02-06

  • Sponsor

    Texas Tech University

  • Condition Name

    Multiple Drug Use

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.